Table 2 Clinical features of the patient with ICSI treatment
Male age (y) | 29 |
Female age (y) | 26 |
Length of primary infertility history (y) | 6 |
BMI (kg/m2) | 21.63 |
Basal hormones | |
 FSH (IU/L) | 5.7 |
 LH (IU/L) | 6.3 |
 E2 (pg/mL) | 131 |
 PRL (ng/ml) | 475.5 |
 Prog (ng/ml) | 1.0 |
 Testo (ng/ml) | 0.4 |
Cycle 1 | |
 Protocol | Long |
 E2 level on the trigger day (pg/mL) | 3383 |
 No. of follicles ≥14 mm on the trigger day | 16 |
 No. of follicles ≥18 mm on the trigger day | 3 |
 No. of oocytes retrieved | 30 |
 No. of mature oocytes | 24 |
ICSI progress | |
 Oocytes injected | 24 |
 Fertilization rate (%) | 16.7% (4) |
 Cleavage Rate (%) | 12.5% (3) |
 6 cell formation rate (%) | 0 |
 8 cell formation rate (%) | 0 |
Cycle 2 | |
 Protocol | Long |
 E2 level on the trigger day (pg/mL) | 3845 |
 No. of follicles ≥12 mm on the trigger day | 19 |
 No. of oocytes retrieved | 10 |
 No. of mature oocytes | 10 |
AOA-ICSI progress | |
 Oocytes injected | 10 |
 Fertilization rate (%) | 100% (10) |
 Cleavage Rate (%) | 100% (10) |
 6 cell formation rate (%) | 80% (8) |
 8 cell formation rate (%) | 40% (4) |